Analysis of Diabetes Apps to Assess Privacy-Related Permissions: Systematic Search of Apps
- PMID: 33439129
- PMCID: PMC7840294
- DOI: 10.2196/16146
Analysis of Diabetes Apps to Assess Privacy-Related Permissions: Systematic Search of Apps
Abstract
Background: Mobile health has become a major vehicle of support for people living with diabetes. Accordingly, the availability of mobile apps for diabetes has been steadily increasing. Most of the previous reviews of diabetes apps have focused on the apps' features and their alignment with clinical guidelines. However, there is a lack of knowledge on the actual compliance of diabetes apps with privacy and data security guidelines.
Objective: The aim of this study was to assess the levels of privacy of mobile apps for diabetes to contribute to the raising of awareness of privacy issues for app users, developers, and governmental data protection regulators.
Methods: We developed a semiautomatic app search module capable of retrieving Android apps' privacy-related information, particularly the dangerous permissions required by apps, with the aim of analyzing privacy aspects related to diabetes apps. Following the research selection criteria, the original 882 apps were narrowed down to 497 apps that were included in the analysis.
Results: Approximately 60% of the analyzed diabetes apps requested potentially dangerous permissions, which pose a significant risk to users' data privacy. In addition, 28.4% (141/497) of the apps did not provide a website for their privacy policy. Moreover, it was found that 40.0% (199/497) of the apps contained advertising, and some apps that claimed not to contain advertisements actually did. Ninety-five percent of the apps were free, and those belonging to the "medical" and "health and fitness" categories were the most popular. However, app users do not always realize that the free apps' business model is largely based on advertising and, consequently, on sharing or selling their private data, either directly or indirectly, to unknown third parties.
Conclusions: The aforementioned findings confirm the necessity of educating patients and health care providers and raising their awareness regarding the privacy aspects of diabetes apps. Therefore, this research recommends properly and comprehensively training users, ensuring that governments and regulatory bodies enforce strict data protection laws, devising much tougher security policies and protocols in Android and in the Google Play Store, and implicating and supervising all stakeholders in the apps' development process.
Keywords: dangerous permissions; diabetes mellitus; mobile apps; privacy.
©José Javier Flors-Sidro, Mowafa Househ, Alaa Abd-Alrazaq, Josep Vidal-Alaball, Luis Fernandez-Luque, Carlos Luis Sanchez-Bocanegra. Originally published in JMIR Diabetes (http://diabetes.jmir.org), 13.01.2021.
Conflict of interest statement
Conflicts of Interest: LF-L is co-founder of Adhera Health Inc (USA), a digital health company that provides digital therapeutic solutions for people with chronic conditions
Figures
Similar articles
-
Exploration of Reproductive Health Apps' Data Privacy Policies and the Risks Posed to Users: Qualitative Content Analysis.J Med Internet Res. 2025 Mar 5;27:e51517. doi: 10.2196/51517. J Med Internet Res. 2025. PMID: 40053713 Free PMC article.
-
Data Management and Privacy Policy of COVID-19 Contact-Tracing Apps: Systematic Review and Content Analysis.JMIR Mhealth Uhealth. 2022 Jul 12;10(7):e35195. doi: 10.2196/35195. JMIR Mhealth Uhealth. 2022. PMID: 35709334 Free PMC article.
-
Smartphone Users' Persuasion Knowledge in the Context of Consumer mHealth Apps: Qualitative Study.JMIR Mhealth Uhealth. 2021 Apr 13;9(4):e16518. doi: 10.2196/16518. JMIR Mhealth Uhealth. 2021. PMID: 33847596 Free PMC article.
-
Medication Management Apps for Diabetes: Systematic Assessment of the Transparency and Reliability of Health Information Dissemination.JMIR Mhealth Uhealth. 2020 Feb 19;8(2):e15364. doi: 10.2196/15364. JMIR Mhealth Uhealth. 2020. PMID: 32130163 Free PMC article.
-
Privacy, Data Sharing, and Data Security Policies of Women's mHealth Apps: Scoping Review and Content Analysis.JMIR Mhealth Uhealth. 2022 May 6;10(5):e33735. doi: 10.2196/33735. JMIR Mhealth Uhealth. 2022. PMID: 35522465 Free PMC article.
Cited by
-
Pulse Oximeter App Privacy Policies During COVID-19: Scoping Assessment.JMIR Mhealth Uhealth. 2022 Jan 27;10(1):e30361. doi: 10.2196/30361. JMIR Mhealth Uhealth. 2022. PMID: 35084348 Free PMC article.
-
Self-Management Support Apps for Spinal Cord Injury: Results of a Systematic Search in App Stores and Mobile App Rating Scale Evaluation.JMIR Mhealth Uhealth. 2024 Dec 19;12:e53677. doi: 10.2196/53677. JMIR Mhealth Uhealth. 2024. PMID: 39700493 Free PMC article.
-
Integrated Digital Health Solutions in the Management of Growth Disorders in Pediatric Patients Receiving Growth Hormone Therapy: A Retrospective Analysis.Front Endocrinol (Lausanne). 2022 Jun 30;13:882192. doi: 10.3389/fendo.2022.882192. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35846336 Free PMC article.
-
Understanding Device Integrations Within Diabetes Apps: Mixed Methods Analysis of App Features and User Reviews.JMIR Diabetes. 2025 May 27;10:e62926. doi: 10.2196/62926. JMIR Diabetes. 2025. PMID: 40424579 Free PMC article.
-
Mobile Applications in Mood Disorders and Mental Health: Systematic Search in Apple App Store and Google Play Store and Review of the Literature.Int J Environ Res Public Health. 2022 Feb 15;19(4):2186. doi: 10.3390/ijerph19042186. Int J Environ Res Public Health. 2022. PMID: 35206373 Free PMC article. Review.
References
-
- World Health Organization. Geneva: WHO Library; 2016. Global report on diabetes; pp. 1–88.
-
- Bourne RRA, Stevens GA, White RA, Smith JL, Flaxman SR, Price H, Jonas JB, Keeffe J, Leasher J, Naidoo K, Pesudovs K, Resnikoff S, Taylor HR. Causes of vision loss worldwide, 1990–2010: a systematic analysis. The Lancet Global Health. 2013 Dec;1(6):e339–e349. doi: 10.1016/S2214-109X(13)70113-X. - DOI - PubMed
-
- Klonoff DC. The current status of mHealth for diabetes: will it be the next big thing? J Diabetes Sci Technol. 2013 May 01;7(3):749–58. doi: 10.1177/193229681300700321. http://europepmc.org/abstract/MED/23759409 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources